Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Clinical trials sponsored by Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., explained in plain language.
Pharmaceutical company, subsidiary of Huadong Medicine.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill HDM2006 tested in patients with advanced cancers Results expected Sep 2026 (estimated)
- New weekly shot aims to shed pounds in obesity trial Results expected Sep 2026 (estimated)
- New Drug's heart safety checked in healthy volunteers Results expected Sep 2026 (estimated)
- Does it matter where you inject? scientists test Weight-Loss drug in arm, thigh, and belly Results expected Oct 2026 (estimated)
- New diabetes pill HDM1002 enters final testing phase Results expected Oct 2026 (estimated)